Search Reports

Showing search results for "All"

Below you can search for shortage and discontinuation reports that have been submitted for drug products by a company.

For more information on how to search reports, see “How to Search” section in the Website overview for public users, found in the About & Resources page.

The “Export results” button on the search reports page will create individual CSV files for shortage reports and discontinuation reports containing data from the search results. Please note that the two CSV files will be downloaded in a single .zip file. Users would then need to open the .zip file to access the CSV files.

To search by product, please refer to the Search Product page.

A public access API (application program interface) is also available to access shortage and discontinuation report data in an alternative format. Access the API here.

The export is also available for download through an extract zip file that is updated monthly. Access the Monthly Report extract here.

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

To
Select from the options in the checkboxes/dropdown menu below to filter your results by report type.
Filter by reports that have been designated Tier 3 by Health Canada. Learn more
Select from the options in the checkboxes/dropdown menu below to filter your results by status type

Status Brand name Company Name Strength(s) Date Updated View Report
Avoided shortage MYLAN-NITRO PATCH 0.6 MYLAN PHARMACEUTICALS ULC 62.2MG 2017-12-20 4086
Resolved INCRUSE ELLIPTA GLAXOSMITHKLINE INC 62.5MCG 2023-01-04 178691
Resolved INCRUSE ELLIPTA GLAXOSMITHKLINE INC 62.5MCG 2019-03-02 76337
Resolved INCRUSE ELLIPTA GLAXOSMITHKLINE INC 62.5MCG 2020-02-06 101563
Resolved CLAVULIN 250 F ORAL SUS GLAXOSMITHKLINE INC 62.5MG 250MG 2022-10-27 166417
Actual shortage JAMP AMOXI CLAV SUSPENSION JAMP PHARMA CORPORATION 62.5MG 250MG 2025-12-10 264314
Resolved CLAVULIN 250 F ORAL SUS GLAXOSMITHKLINE INC 62.5MG 250MG 2024-02-14 175255
Resolved SANDOZ BOSENTAN SANDOZ CANADA INCORPORATED 62.5MG 2018-04-13 38711
Discontinued PMS-BOSENTAN PHARMASCIENCE INC 62.5MG 2021-03-19 135510
Discontinued MYLAN-BOSENTAN MYLAN PHARMACEUTICALS ULC 62.5MG 2018-07-04 53603
Resolved MYLAN-BOSENTAN MYLAN PHARMACEUTICALS ULC 62.5MG 2018-07-03 23157
Resolved TARO-BOSENTAN TARO PHARMACEUTICALS INC 62.5MG 2025-08-12 259468
Actual shortage NAT-BOSENTAN NATCO PHARMA (CANADA) INC 62.5MG 2025-07-03 243351
Discontinued APO-BOSENTAN APOTEX INC 62.5MG 2019-01-04 71339
Resolved TARO-BOSENTAN TARO PHARMACEUTICALS INC 62.5MG 2023-07-18 173499
Resolved ULTRAVIST 300 BAYER INC 62% 2024-09-05 224122
Actual shortage ULTRAVIST 300 BAYER INC 62% 2025-10-21 224127
Resolved ULTRAVIST 300 BAYER INC 62% 2024-06-03 215772
Resolved APO-COLESEVELAM APOTEX INC 625MG 2023-02-09 173826
Resolved LODALIS BAUSCH HEALTH, CANADA INC. 625MG 2020-09-10 122119

Showing 25721 to 25740 of 27806